Investors seeking relief from stock market volatility should take a closer look at Bristol Myers Squibb (NYSE: BMY). At the…
Amgen (AMGN) concluded the recent trading session at $311.55, signifying a +1.5% move from its prior days close.…
Dividend investing is an excellent strategy for (at least) two reasons. Companies that can provide consistent payouts generally have robust…
Four of the 30 stocks that make up the Dow Jones Industrial Average represent the healthcare sector. Within that group,…
As ever in the often quick-developing biotech and pharmaceutical sectors on Tuesday, companies posted a mix of positive and negative…
deCODE genetics: Reykjavik, Island, 25. März 2025 (ots/PRNewswire) - Wissenschaftler von deCODE genetics, einer Tochtergesellschaft von Amgen, zeigen heute in…
The Dow Jones Industrial Average (DJINDICES: ^DJI) has changed a lot in recent years. In 2020, Salesforce, Amgen, and Honeywell…
In the latest trading session, Amgen (AMGN) closed at $314.38, marking a -0.53% move from the previous day.…
Whether youre a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top…
Amgen outlook revised to positive by Fitch, ratings affirmed…
Dr. Reddy and Alvotech announce the FDA acceptance of the BLA for their proposed biosimilar candidate of Amgens Prolia and…
Amgen (AMGN) concluded the recent trading session at $318.65, signifying a +0.47% move from its prior days close.…
AMGNs consistent top-line growth, an interesting pipeline and rising estimates are good enough reasons to stay invested in the stock…
Equity markets can move every which way from one day to the next. The more we extend our horizon, the…
The latest trading day saw Amgen (AMGN) settling at $317.17, representing a +1.1% change from its previous close.…
Lets say you have some money in your pocket you want to invest, but youre not sure where to put…
Its time for another round of The Market Cap Game Show on Rule Breaker Investing. Remember that market cap calculates…
Der führende Biotechnologiekonzern Amgen steht aktuell an einem entscheidenden Punkt, während die Finanzmärkte mit Unsicherheiten kämpfen. Der Aktienkurs des Unternehmens…
Like many pharma stocks, Eli Lilly (NYSE: LLY) offers investors a bit of safety -- and its an element you…
In der jüngeren Vergangenheit konnte Amgen mit verheißungsvollen News zu einem Adipositas-Medikament und einer Dividenden-Erhöhung glänzen (DER AKTIONÄR berichtete). Am…
Kulmbach (www.aktiencheck.de) - Amgen-Aktienanalyse von "Der Aktionär":
Martin Mrowka vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Amgen Inc. (ISIN: US0311621009,…
Data from two more late-stage studies show that treatment with Amgens rocatinlimab improves outcomes in atopic dermatitis indication.…
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the…
Biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) saw its fortunes reversed last year. Though the drugmaker had performed well since the…
Its often challenging to decide which stocks to invest in. However, some companies look too attractive to pass up. We…
Dividend investors dont buy shares of companies hoping they will suspend their payouts soon. The longer a corporation maintains its…
Amgen (AMGN) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings estimates for…
NEW YORK, March 05, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
MariTide is a monthly injection that investors hope could compete against existing weight loss drugs from Novo Nordisk and Eli…
The S&P 500 (SNPINDEX: ^GSPC) is widely considered the best gauge for the overall U.S. stock market due to its…
The GLP-1 weight loss market is a massive one, with some analysts expecting it to be worth around $200 billion…
…
How is the Dow Jones Industrial Average (DJINDICES: ^DJI) performing this year? It might depend on whether you view the…
AbbVie, Amgen, Stryker, Dexcom and Medtronic are included in this Analyst Blog.…
By Rishika Sadam HYDERABAD, India (Reuters) -U.S. drugmaker Amgen will invest about $200 million this year in its new technology…
HYDERABAD, India (Reuters) -U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern…
U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further…
Dublin, Feb. 21, 2025 (GLOBE NEWSWIRE) -- The "Nebulizer Patent Landscape Report" report has been added to …
…
Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The companys results were…
Who doesnt want passive income? Even Warren Buffett has extolled it, reportedly saying, "If you dont find a way to…
…
Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Genomic Data Analysis and Interpretation Market Opportunities and Strategies to…
Amgens EVP Jonathan Graham sells $7.34 million in stock…
Investing in stocks that arent performing well can be a good move, but only if there are good reasons to…
Investors looking for ways to pump up their passive income streams might want to turn their heads toward the pharmaceutical…
February is the shortest month, but that doesnt mean income investors dont have much time to find great stocks. Three…
Amgen SVP Nancy Grygiel sells stock for $483,807…
Amgen, CRISPR, Moderna, Sarepta and Vertex are included in this Analyst Blog.…
^BURLINGAME, Kalifornien, Feb. 05, 2025 (GLOBE NEWSWIRE) Accumulus Synergy(?Accumulus") hat in einem branchenweit einmaligen Moment den bahnbrechendenZulassungsantrag von Amgen…